Last update :
16/06/2025
Stability and compatibility of drugs

Welcome in Stabilis. If you wish to receive the quarterly newsletter, indicate your email address.

Sign up

If you have any questions or comments, please contact : infostab@stabilis.org

Database  
References : 2835
Compounds : 881
Pharmacological Class : 46
Stability of solutions : 6631
Stability in mixtures : 1261
Compatibility : 12758
Trade Name : 4596
News - Compounds  
Anticancer drug injection Elranatamab 10/06/2025
Various Ointments Azelaique acide 29/05/2025
Anti-inflammatory Ointments Hydrocortisone 29/05/2025
Diuretic Ointments Spironolactone 28/05/2025
Hormone Ointments Melatonine 27/05/2025
Antibiotic Ointments Metronidazole 27/05/2025
Various Ointments Finasteride 13/05/2025
Various Oral solution Dextrose 13/05/2025
Antibiotic Capsule Amoxicilline 05/04/2025
Anticancer drug injection Glofitamab 16/03/2025
Anticancer drug injection Tafasitamab 16/03/2025
Anticancer drug injection Teclistamab 16/03/2025
Anticancer drug injection Cemiplimab 16/03/2025
Anticancer drug injection Tremelimumab 16/03/2025
Antibiotic Ointments Ceftriaxone disodium 12/03/2025
Vitamin Ointments Pyridoxine hydrochloride 04/03/2025
Anti-inflammatory Ointments Hydrocortisone acetate 04/03/2025
Anticancer drug injection Dostarlimab 03/03/2025
Hormone nasal drops Desmopressine acetate 12/02/2025
Antihypertensive Oral solution Olmesartan medoxomil 12/02/2025
News - References  
Date of Entry
4945 Iloprost 100 micrograms/ml concentrate for solution for infusion - Summary of Product Characteristics Updated 12-Oct-2023. Colonis Pharma Ltd 01/06/2025
4943 Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use Antibiotics 21/05/2025
4942 Elranatamab (ELREXFIO) - Information Médicale PFIZER Pfizer 19/05/2025
4935 Physicochemical stability of mixtures of nonsteroidal anti-inflammatory drugs such as ketorolac and diclofenac and antiemetics such as ondansetron and ramosetron: an in vitro study. Korean J Pain 23/04/2025
4936 Stability of Daptomycin in Dextrose and Icodextrin-Based Peritoneal Dialysis Solutions. Can J Anesth 23/04/2025
4932 Physical stability of bevacizumab solutions for intravitreal injections: Influence of conditioning material and storage conditions. Pharmaceuticals 21/04/2025
4928 Compatibility tests - march 2025. Newsletter INFOSTAB 68 - march 2025 07/04/2025
4929 Long-term Physicochemical Stability of a Pharmaceutical Preparation of Morphine Hydrochloride and Droperidol in Polypropylene Syringes. Int J Pharm Compound 07/04/2025
4931 Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm, a Cream Base for Personalized Dermatological Treatments. Int J Pharm Compound 07/04/2025
4924 Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings EJHP 26/03/2025
4921 Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride, Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions. Int J Pharm Compound 12/03/2025
4920 Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel. Pharmaceuticals 04/03/2025
4919 Dostarlimab (Jemperli®) – Résumé des caractéristiques du produits 03/03/2025
4917 A Physicochemical Stability Study of Pembrolizumab Vial Leftovers: Let Us Stop Pouring Good Money Down the Drain. Pharmacy 18/02/2025
4916 Stability Over Time of In-Hospital-Compounded Amoxicillin Capsules and Ceftriaxone Patch Tests for Drug Allergy Testing. J Investig Allergol Clin Immunol 16/02/2025
4914 In‐Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions. Drugs R D 02/02/2025
4911 Glofitamab (Columvi®) - Résumé des caractéristiques du produit 28/01/2025
4912 Tafasitamab (Minjuvi®) - Résumé des caractéristiques du produit Incyte Biosciences 28/01/2025
4913 Teclistamab (Tecvayli®) - Résumé des caractéristiques du produit Janssen-Cilag International NV 28/01/2025
4904 Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation. EJHP 15/01/2025
4905 Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration Pharmaceuticals 15/01/2025
4893 Stability and Sterility of Extemporaneously Prepared .01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution. Siriraj Medical Journal 07/01/2025
4894 Chemical stability of pharmacy-compounded cefazolin sodium eye drops. Pharm Chem J 07/01/2025
4895 Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial for Cost Savings. JCO Oncology Practice 07/01/2025
4891 Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophtalmol Ther 06/01/2025
4892 Combined physicochemical and functional assessment of pertuzumab integrity supports extended in‐use stability. Arch Pharm 06/01/2025
4888 Stabilité du propofol, du rocuronium, du phénobarbital et du magnésium injectables reconditionnés en seringue pour les trousses d’aide médicale à mourir. Pharmactuel 01/01/2025
4887 IMJUDO (tremelimumab) 20 mg/mL concentrate for solution for infusion. Summary of Product Characteristics. Astra Zenaca AB 14/12/2024
4886 Physicochemical and Microbiological Stability of Ursodiol Oral Compounded Suspensions. J Pediatr Pharmacol Ther 11/12/2024
4884 Stability of Diluted Desmopressin Acetate Intranasal Solution at 0.01 mg/mL. Int J Pharm Compound 06/12/2024

  Mentions Légales